J. Brown

发表

Integrating phenotypic and expression profiles to map arsenic-response networks

T. Ideker, R. Kelley, A. Haugen, 2004, Genome Biology.

Exploiting tumour hypoxia in cancer treatment

J. Brown, W. Wilson, J. Brown, 2004, Nature Reviews Cancer.

The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice.

J. Brown, R. Carmel, J. Brown, 1977, Cancer research.

The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction.

A. Giaccia, J. Brown, C. Koumenis, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: in vitro and xenograft studies.

J. Brown, D. Vordermark, J. Brown, 2003, International journal of radiation oncology, biology, physics.

A comparison of radiosensitization by etanidazole and pimonidazole in mouse tumors.

J. Brown, H. Stone, V. Hirst, 1991, International journal of radiation oncology, biology, physics.

The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

A. Giaccia, J. Brown, Janice M. Y. Brown, 1998, Cancer research.

Clinical Cancer esearch cer Therapy : Preclinical rmacokinetic / Pharmacodynamic Modeling Identifies 0000 and SN 29751 as Tirapazamine Analogues with roved Tissue Penetration and Hypoxic R l Killing in Tumors

W. Denny, J. Brown, W. Wilson, 2010 .

Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies.

J. Brown, J M Brown, JM Brown, 2000, Molecular medicine today.

Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

T L Phillips, T. Phillips, J. Brown, 1993, Radiation research.

Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.

B. Loo, M. Diehn, J. Brown, 2010, International journal of radiation oncology, biology, physics.

Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism.

A. Giaccia, J. Brown, B. Wouters, 1997, Cancer research.

The Promise of Targeting Macrophages in Cancer Therapy

L. Recht, J. Brown, S. Strober, 2017, Clinical Cancer Research.

The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding.

J. Brown, M. Lemmon, I. Kim, 1993, Radiation research.

Computerized histographic oxygen tension measurements of murine tumors.

J. Brown, D. Terris, A. Minchinton, 1992, Advances in experimental medicine and biology.

scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair.

A. Giaccia, J. Brown, J. R. Sun, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Enhancement of Alkylating Agent Cytotoxicity by Radiation Sensitizers

D. Hirst, J. Brown, M. Horsman, 1986 .

The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.

J. Brown, J. Brown, J. Brown, 1982, International journal of radiation oncology, biology, physics.

Meeting of the minds on mercury.

J. Brown, P. Workman, N. Yu, 1979, British Journal of Cancer.

Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.

J. Brown, G. Ahn, M. Dorie, 2008, Cancer research.

Bacterial Systems for Tumor-Specific Gene Therapy

P. Lambin, J. Brown, J. Theys, 2005 .

The pharmacokinetics and tumor and neural tissue penetrating properties of SR-2508 and SR-2555 in the dog--hydrophilic radiosensitizers potentially less toxic than misonidazole.

J. Brown, P. Workman, R. White, 1980, Radiation research.

Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole.

J. Brown, P. Workman, J. Brown, 1980, Radiation research.

The use of asymmetric-field inversion gel electrophoresis to predict tumor cell radiosensitivity.

A. Giaccia, J. Brown, J. Schwartz, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine.

D. Bloch, Q. Le, J. Brown, 1999, Neoplasia.

In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma.

B. Narasimhan, A. Koong, E. Graves, 2008, International journal of radiation oncology, biology, physics.

Radiosensitization, thiol oxidation, and inhibition of DNA repair by SR 4077.

J. Brown, Y. Taylor, M. A. Baker, 1988, Radiation research.

Tirapazamine: a new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer.

J. Brown, B. Wouters, L. Wang, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.

J. Brown, M. Dorie, D. Menke, 1994, International journal of radiation oncology, biology, physics.

Discrepancies between measured changes of radiobiological hypoxic fraction and oxygen tension monitoring using two assay systems.

J. Brown, K. Sasai, J. Brown, 1994, International journal of radiation oncology, biology, physics.

Toxicology of daily administration to mice of the radiation potentiator SR 4233 (WIN 59075).

J. Brown, M. Spear, J. F. Spiegel, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The tumour microenvironment and cellular hypoxia responses

J. Brown, B. Wouters, A. J. van der Kogel, 2018, Basic Clinical Radiobiology.

A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy

A. Giaccia, J. Brown, B. Wouters, 1999, Oncogene.

Deficiency in Bre1 Impairs Homologous Recombination Repair and Cell Cycle Checkpoint Response to Radiation Damage in Mammalian Cells

J. Brown, O. Razorenova, J. Game, 2010, Radiation research.

Sensitizers in Radiotherapy

J. Brown, J. Brown, J. Brown, 1988 .

18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy.

B. Loo, M. Diehn, A. Koong, 2018, International journal of radiation oncology, biology, physics.

Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction.

A. Koong, A. Giaccia, J. Brown, 1994, International journal of radiation oncology, biology, physics.

Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferase.

D. M. Brown, D. Hirst, J. Brown, 1986, British Journal of Cancer.

Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.

D. M. Brown, J. Brown, M. Lemmon, 1986, International journal of radiation oncology, biology, physics.

Mechanism of action of the selective tumor radiosensitizer nicotinamide.

J. Brown, J. Overgaard, M. Lemmon, 1988, International journal of radiation oncology, biology, physics.

Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.

J. Brown, M. Horsman, D. Chaplin, 1989, Radiation research.

Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide.

J. Brown, M. Lemmon, M. Horsman, 1991, International journal of radiation biology.

The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.

J. Brown, R. Kallman, P. Lelieveld, 1985, International journal of radiation oncology, biology, physics.

4 – Chemical Modifiers of Radiation Response

J. Brown, C. Koch, M. Parliament, 2010 .

Tumor and Stem Cell Biology De fi ciency in Mammalian Histone H 2 B Ubiquitin Ligase Bre 1 ( Rnf 20 / Rnf 40 ) Leads to Replication Stress and Chromosomal Instability

J. Brooks, M. Nicolau, J. Higgins, 2012 .

Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability.

J. Brooks, M. Nicolau, J. Higgins, 2012, Cancer research.

J. Brown, D. Vordermark, D. Menke, 2003, Radiation research.

Pre- and post-irradiation radiosensitization by SR 4233.

J. Brown, E. M. Zeman, J. Brown, 1989, International journal of radiation oncology, biology, physics.

Comparison between X-rays and SR 4233 for cytotoxicity and repair of potentially lethal damage in human cells.

J. Brown, K. Biedermann, J. Brown, 1989, International journal of radiation biology.

Aerobic radiosensitization by SR 4233 in vitro and in vivo.

J. Brown, M. Lemmon, E. M. Zeman, 1990, International journal of radiation oncology, biology, physics.

Pre- and post-irradiation adiosensitization by SR 4233

J. Brown, E. M. Zeman, J. Brown, 1989 .

Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.

J. Brown, J. R. Sun, J. Brown, 1989, Cancer research.

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.

D. Hirst, J. Brown, J. Hazlehurst, 1982, British Journal of Cancer.

Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.

J. Brown, M. Dorie, D. Menke, 1999, Radiation oncology investigations (Print).

Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.

J. Brown, B. Wouters, J. Brown, 1997, Radiation research.

Chemotherapeutic tumour targeting using clostridial spores.

A. Giaccia, J. Brown, M. Lemmon, 1995, FEMS microbiology reviews.

Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiation.

J. Brown, M. Lemmon, J. Brown, 1991, International journal of radiation oncology, biology, physics.

Exploiting tumour hypoxia and overcoming mutant p53 with tirapazamine.

J. Brown, J. Brown, 1998, British Journal of Cancer.

Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion.

J. Brown, H. Stone, A. Minchinton, 1992, International journal of radiation oncology, biology, physics.

NCI's anticancer drug screening program may not be selecting for clinically active compounds.

J. Brown, J. Brown, J. Brown, 1997, Oncology research.

Transcriptional activation of hypoxia-inducible factor-1 (HIF-1) in myeloid cells promotes angiogenesis through VEGF and S100A8

K. S. Kim, I. Weissman, J. Cooke, 2014, Proceedings of the National Academy of Sciences.

Selective Potentiation of the Hypoxic Cytotoxicity of Tirapazamine by Its 1-N-Oxide Metabolite SR 4317

J. Brown, W. Wilson, M. Hay, 2004, Cancer Research.

Radiation Damage to Tumor Vasculature Initiates a Program that Promotes Tumor Recurrences.

J. Brown, J. Brown, J. Brown, 2020, International journal of radiation oncology, biology, physics.

Therapeutic advantage of hypoxic cells in tumors: a theoretical study.

A. Koong, J. Brown, J. Brown, 1991, Journal of the National Cancer Institute.

Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent.

J. Brown, E. Bernhard, D. Deen, 2000, Cancer research.

Designing phase II trials in cancer: a systematic review and guidance

M. Buyse, W. Gregory, J. Brown, 2011, British Journal of Cancer.

Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.

J. Brown, D. Cole, J. Vournakis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Characterization of a sustained-release delivery system for combined cytokine/peptide vaccination using a poly-N-acetyl glucosamine-based polymer matrix.

J. Brown, D. Cole, J. Vournakis, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

110 Tumor-specific gene therapy with a hypoxia inducible vector

A. Giaccia, J. Brown, T. Shibata, 1999 .

Structural and conformational analysis of glycan moieties in situ on isotopically 13C, 15N-enriched recombinant human chorionic gonadotropin.

R. Canfield, J. Brown, S. Ramnarain, 1996, Biochemistry.

Report of NCI Ad Hoc Working Group on the Risks Associated With Mammography in Mass Screening for the Detection of Breast Cancer

G. Beebe, J. Brown, A. Upton, 1977 .

Neutrophil and monocyte adherence in diabetes mellitus, alcoholic cirrhosis, uraemia and elderly patients.

J. Brown, Y. Thong, M. Kelly, 1985, International archives of allergy and applied immunology.

Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.

J. Brown, J. Vieira, E. Mocarski, 1995, The Journal of general virology.

The hypersensitivity of the Chinese hamster ovary variant BL-10 to bleomycin killing is due to a lack of glutathione S-transferase-alpha activity.

A. Giaccia, J. Brown, N. Denko, 1991, Cancer research.

Cell Death Identification in Anticancer Therapy-Letter.

J. Brown, D. Kirsch, B. Wouters, 2015, Cancer research.

In vivo evaluation of the radiosensitizing and cytotoxic properties of newly synthesized electron-affinic drugs.

J. Brown, D. Taylor, R. Bicknell, 1978, The British journal of cancer. Supplement.

Mural thrombosis of the heart induced by radiation.

J. Brown, J. R. Stewart, L. F. Farjardo, 1973, Archives of pathology.

Formulation development of an antifibrin monoclonal antibody radiopharmaceutical.

J. Brown, G. Tolman, M. Kamat, 1996, Pharmaceutical biotechnology.

Genetically modified clostridium for gene therapy of tumors.

A. Giaccia, J. Brown, M. Lemmon, 2000, Methods in molecular medicine.

Hypoxic cytotoxic agents: a new approach to cancer chemotherapy.

J. Brown, J. Brown, J. Brown, 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Reoxygenation and rehypoxiation in the SCCVII mouse tumor.

J. Brown, I. Kim, J. Brown, 1994, International journal of radiation oncology, biology, physics.

Tirapazamine is metabolized to its DNA-damaging radical by intranuclear enzymes.

J. Brown, K. Yudoh, J. Evans, 1998, Cancer research.

Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation.

J. Brown, K. Biedermann, J. Wang, 1992, Cancer research.

Sensitizers and protectors in radiotherapy

J. Brown, J. Brown, J. Brown, 1985, Cancer.

Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation.

B. Strulovici, A. Giaccia, J. Brown, 1992, British Journal of Cancer.

Induction and repair of chromosome aberrations in scid cells measured by premature chromosome condensation.

J. Brown, C. Kirchgessner, J. Evans, 1996, Radiation research.

Characterization of the DNA double strand break repair defect in scid mice.

J. Brown, M. Mezzina, C. Chang, 1993, Cancer research.

Activation of the heat shock transcription factor by hypoxia in normal and tumor cell lines in vivo and in vitro.

G. Hahn, A. Koong, A. Giaccia, 1992, International journal of radiation oncology, biology, physics.

Improved sarcoma imaging and reduced hepatic activity with indium-111-SCN-Bz-DTPA linked to MoAb 19-24.

M. Brechbiel, J. Brown, T. K. Das Gupta, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Multimodal Concepts for Integration of Cytotoxic Drugs

M. Mehta, J. Brown, C. Nieder, 2006 .

R-loops and genomic instability in Bre1 (RNF20/40)-deficient cells

J. Brown, S. Chernikova, Martin Brown, 2012, Cell cycle.

Comparison of intravenous and intra-arterial pyrimidine infusion as a means of radiosensitizing tumors in vivo.

J. Brown, D. Goffinet, J. Brown, 1977, Radiology.

Radiation injury in the mouse kidney--I. Sequential light microscopic study.

L. F. Fajardo, J. Brown, E. Glatstein, 1977, International journal of radiation oncology, biology, physics.

Glomerular and juxta-glomerular lesions in radiation nephropathy.

L. F. Fajardo, J. Brown, E. Glatstein, 1976, Radiation research.

Cardiac mural thrombi caused by radiation.

L. F. Fajardo, J. Brown, J. Brown, 1973, Radiation research.

Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay.

A. Koong, Q. Le, J. Brown, 2002, Archives of otolaryngology--head & neck surgery.

Monoclonal antibody identification and characterization of two human sarcoma-associated antigens.

J. Brown, C. Beattie, T. K. Das Gupta, 1991, Cancer research.

Localization of radiolabeled monoclonal antibody in a human soft tissue sarcoma xenograft.

J. Brown, T. K. Gupta, J. Greager, 1985, Journal of the National Cancer Institute.

Detection of a human sarcoma-associated antigen with monoclonal antibodies.

J. Brown, J. Brown, J. Brown, 1983, Cancer research.

Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.

D. Hirst, J. Brown, J. Hazlehurst, 1983, Cancer research.

Role of glutathione in the hypoxic cell cytotoxicity of misonidazole.

J. Brown, E. Bump, Y. Taylor, 1983, Cancer research.

Role of Glutathione in the Hypoxie Cell Cytotoxicity of Misonidazole1

J. Brown, E. Bump, Y. Taylor, 1983 .

Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine

J. Brown, M. Dorie, J. Brown, 1997, Cancer Chemotherapy and Pharmacology.

Second-generation 1,2,4-benzotriazine 1,4-di-N-oxide bioreductive anti-tumor agents: pharmacology and activity in vitro and in vivo.

J. Brown, M. Lemmon, A. Minchinton, 1992, International journal of radiation oncology, biology, physics.

Misonidazole chemosensitization of EMT6 spheroids to melphalan.

J. Brown, M. Horsman, P. Wood, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Thermoradiotherapy for persistent cancer in previously irradiated fields

J. Brown, H. W. Baker, P. Snedecor, 1986, Cancer.

The frequency of translocations after treatment for Hodgkin's disease.

J. Brown, L. Smith, M. Mori, 1992, International journal of radiation oncology, biology, physics.

Structure-pharmacokinetic relationships for misonidazole analogues in mice

J. Brown, P. Workman, J. Brown, 2004, Cancer Chemotherapy and Pharmacology.

Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophages.

S. Zamvil, J. Brown, P. Twentyman, 1980, Journal of the National Cancer Institute.

Role of the adenylate energy charge in the response of Chinese hamster ovary cells to radiation.

J. Brown, E. Bump, S. Calderwood, 1984, International journal of radiation oncology, biology, physics.

Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.

J. Brown, J. Brown, J. Brown, 1975, Radiation research.

The effect of alterations in haematocrit on tumour sensitivity to X-rays.

D. Hirst, J. Brown, J. Hazlehurst, 1984, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Tumor hypoxia is important in radiotherapy, but how should we measure it?

Q. Le, J. Brown, J. Brown, 2002, International journal of radiation oncology, biology, physics.

Cell status — dead or alive?

J. Brown, J. Brown, J. Brown, 1996, Nature Medicine.

Is Equipment Development Stifling Innovation in Radiation Oncology?

J. Adler, J. Brown, J. Brown, 2015, International journal of radiation oncology, biology, physics.

Potentiation by the Hypoxie Cytotoxin SR 4233 of Cell Killing Produced by Fractionated Irradiation of Mouse Tumors1

J. Brown, M. Lemmon, 2006 .

Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing.

J. Brown, A. Minchinton, J. Brown, 1992, British Journal of Cancer.

Hydralazine does not increase hypoxia in tumors growing in preirradiated tissue.

J. Brown, M. Lemmon, J. Brown, 1991, International journal of radiation oncology, biology, physics.

SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes.

J. Brown, M. Lemmon, J. Brown, 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Redox Activation of Benzotriazine N-Oxides: Mechanisms and Potential as Anticancer Drugs

J. Brown, 1990 .

Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome.

J. Brown, E. Mocarski, M. Prichard, 1997, Virology.

Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: a preliminary report.

J. Brown, N. Yu, J. Brown, 1984, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--II. Cyclophosphamide.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. V. Bleomycin.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors. III. Cis-diamminedichloroplatinum.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The effect of time between X-irradiation and chemotherapy on the growth of three solid mouse tumors--I. Adriamycin.

J. Brown, P. Twentyman, R. Kallman, 1979, International journal of radiation oncology, biology, physics.

The Biology of SBRT: LQ or Something New?

J. Brown, J. Brown, 2018, International journal of radiation oncology, biology, physics.

In Regard to Song et al.

J. Brown, D. Carlson, J. Brown, 2020, International journal of radiation oncology, biology, physics.

Mechanism of sensitization of Chinese hamster ovary cells to melphalan by hypoxic treatment with misonidazole.

J. Brown, Y. Taylor, J. Evans, 1983, Cancer research.

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Irving L. Weissman, Michael F. Clarke, Maximilian Diehn, 2009, Nature.

The spectrum of beta thalassaemia in Burma.

J. Brown, D. Weatherall, S. Thein, 1992, British journal of haematology.

FRACTIONATION INCREASES THE ANTITUMOR EFFECT OF ADDING A HYPOXIC CYTOTOXIN TO IRRADIATION

J. Brown, M. Lemmon, J. Brown, 1992 .

Improving the effectiveness of the bioreductive antitumor agent SR 4233 by induced hypoxia.

J. Brown, A. Minchinton, J. Brown, 1992, Advances in experimental medicine and biology.

The use of drugs which deplete intracellular glutathione in hypoxic cell radiosensitization.

J. Brown, E. Bump, N. Yu, 1982, International journal of radiation oncology, biology, physics.

Gold medal award recipient

J. Brown, 1999 .

Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.

J. Brown, M. Horsman, J. Evans, 1984, British Journal of Cancer.

Changes in misonidazole binding with hypoxic fraction in mouse tumors.

D. Hirst, J. Brown, J. Hazlehurst, 1985, International journal of radiation oncology, biology, physics.

Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.

J. Brown, J. Stafford, S. Chernikova, 2016, Neuro-oncology.

The use of rodent tumors in experimental cancer therapy. Conclusions and recommendations from an international workshop.

J. Brown, R. Hill, J. Denekamp, 1985 .

A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer

M. Muers, J. Brown, M. Peake, 2001, British Journal of Cancer.

Modification of alkylating agent cytotoxicity by cisplatin.

D. M. Brown, D. Hirst, J. Brown, 1984, International journal of radiation oncology, biology, physics.

Corticotropin Deficiency: A Rare Cause of Hyponatremia Mimicking Siadh

J. Brown, D. Cowley, Jennifer M. Brown, 1991, Pathology.

The effects of single and multifraction radiation courses on the mouse spinal cord.

J. Brown, D. Goffinet, G. Marsa, 1976, Radiology.

What role do glutathione S-transferases play in the cellular response to ionizing radiation?

A. Giaccia, J. Brown, A. Lewis, 1992, International journal of radiation oncology, biology, physics.

Isolation of a human lymphocyte mitogen from wheat germ with N-acetyl-D-glucosamine specificity.

J. Brown, M. A. León, J. Lightbody, 1976, Journal of immunology.

Characterization of a CHO cell line resistant to killing by the hypoxic cell cytotoxin SR 4233.

A. Giaccia, J. Brown, A. Minchinton, 1992, International journal of radiation oncology, biology, physics.